Browse studies

Find your next paid study

17 recruiting studies matching your filters

A Clinical Evaluation of the BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber in Subjects With Mild to Moderate Dry Eye Disease

The purpose of this study is to evaluate the short-term effects (impact on tear film and dry eye symptoms) of the BriTer Eyez Moisture Vue™ On-Demand Disposabl…

Dry Eye Disease (DED)

Estimated

~$10 – $6,250

University of RochesterNCT07430735

Phase 2

A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in p…

Dry Eye Disease (DED)

Estimated

~$10 – $7,500

OculisNCT07548632

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.

Fuchs Endothelial Corneal DysfunctionOpen Angle Glaucoma (OAG)Dry Eye Disease (DED)+2 more

Estimated

~$10 – $750

Massachusetts General HospitalNCT07780890

Phase 4

The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free in Providing Relief From Multiple Symptoms of Dry Eye Disease, and Its Impact on Daily Functioning and Overall Comfort in Dry Eye Subjects

The goal of this investigational study is to determine if Systane PRO Preservative Free is non-inferior to BLINK TRIPLE CARE in the clinically significant impr…

Dry Eye Disease (DED)

Estimated

~$10 – $7,500

Gordon Schanzlin New VisionNCT07745062

Phase 4

A Single Center Investigator Initiated Trial Using TRYPTYR as a Treatment for Patients With Dry Eye Disease

The purpose of this research study is to determine the effectiveness of TRYPTYR as a treatment for Dry Eye Disease. The primary efficacy variable is change fro…

Dry Eye Disease (DED)

Estimated

~$10 – $7,500

NYU Langone HealthNCT07732010

Phase 4

A Randomized, Investigator-Masked, Single-Center Study Evaluating Tolerability, Symptomatic Improvement, and Visual Functional Outcomes With the Use of Over-the-Counter Lubricating Eye Drops in Subjects With Dry Eye Disease

A study to evaluate the effect of over- the- counter (OTC) lubricating eye drops on tolerability, symptoms and visual outcomes in patients with dry eye disease…

Dry Eye Disease (DED)

Estimated

~$10 – $7,500

Andover Research Eye InstituteNCT07676084

Phase 2

A 12-Week, Phase 2, Multicenter, Randomized, Double-Masked, Vehicle Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate the Efficacy and Safety of DFL24498 0.08% Topical Ophthalmic Solution Versus Vehicle in Participants With Dry Eye Disease

This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical oph…

Dry Eye Disease (DED)

Estimated

~$10 – $7,500

Dompé Farmaceutici S.p.ANCT07503886

Phase 4

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry …

Dry Eye Syndrome (DES)Dry Eye Disease (DED)

Estimated

~$10 – $7,500

Vance Thompson VisionNCT07650708

Phase 2

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Ad…

Dry Eye Disease

Estimated

~$10 – $8,750

Bausch & Lomb IncorporatedNCT07128628

2177GCCC: Identifying Novel Treatment Targets and Biomarkers for Ocular Surface Disease in Patients With Ocular Graft vs Host Disease (oGVHD) a Biobank Study

Evaluate and study the immunologic changes to the ocular surface in cancer patients.

Dry Eye DiseaseoGVHD

Estimated

~$10 – $750

University of Maryland, BaltimoreNCT04946721

Phase 4

Dry Eye Surveys to Evaluate Acoltremon in Real World Treatment (DESERT)

Dry eye disease (DED) is a common, chronic and multifactorial disease of the ocular surface presenting with signs and symptoms of ocular discomfort, visual dis…

Dry Eye Disease (DED)

Estimated

~$10 – $7,500

Center for Sight Las VegasNCT07281950

Phase 4

Comparing the Efficacy of SYSTANE® PRO to MIEBO™ for the Treatment of Dry Eye Disease

This is a prospective, randomized, double-masked, multi-site clinical trial designed to compare the efficacy of SYSTANE® PRO (Alcon Laboratories, Inc.) to MIEB…

Dry Eye Disease (DED)

Estimated

~$10 – $6,250

Indiana UniversityNCT07243275